OPIS

OPIS is a science-driven biotech focused CRO that was founded in 1998 by medical doctors from the Pharma Industry. With 25 years of experience in a wide range of therapeutic areas, OPIS distinguishes itself as a global clinical CRO that provides full-service, 360° clinical trial support. This includes everything from study concept creation and protocol development to full project execution, study data handling, study closure, analysis, and reporting. The company manages Phase I-IV, interventional, non-interventional, and medical devices studies internationally. Additionally, OPIS also coordinates pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceutical, and food supplement studies.

OPIS's strength lies in its people and specialized teams, which provide medical writing, scientific and statistical consultancy, and skilled operational staff for high-quality project execution. The company's mission is to increase the global development of safe and effective medical therapeutics by leveraging local regulatory and deep therapeutic expertise across major areas such as oncology, cardiology, metabolic disease, endocrinology, central nervous system, etc.

Committed to continuous growth and expansion, OPIS currently has affiliates in 17 countries around the world. With a focus on the pharmaceutical industry, OPIS aims to contribute to the development of safe and effective medical therapeutics globally through its high-science and disciplined operating approach.

For more information, visit www.opisresearch.com